Trofile
Commercial- Indications
- HIV
Company intelligence / Profile preview
Monogram Biosciences has established itself as a leader in commercializing advanced diagnostic assays that guide individualized treatment decisions in HIV, HCV, HBV, SARS-CoV‑2 infections and oncology. Their technologies support both patient care and pharmaceutical R&D by enabling precise drug resistance profiling and biomarker-driven therapy selection. The company’s tests have been widely adopted in clinical practice as well as industry-sponsored trials.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monogram Biosciences.